Cargando…
Roadmap and strategy for overcoming infusion reactions to nanomedicines
Infusion reactions (IRs) are complex, immune-mediated side effects that mainly occur within minutes to hours of receiving a therapeutic dose of intravenously administered pharmaceutical products. These products are diverse and include both traditional pharmaceuticals (for example biological agents a...
Autores principales: | Szebeni, Janos, Simberg, Dmitri, González-Fernández, África, Barenholz, Yechezkel, Dobrovolskaia, Marina A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6320688/ https://www.ncbi.nlm.nih.gov/pubmed/30348955 http://dx.doi.org/10.1038/s41565-018-0273-1 |
Ejemplares similares
-
Understanding the Role of Anti-PEG Antibodies in the Complement Activation by Doxil in Vitro
por: Neun, Barry W., et al.
Publicado: (2018) -
PEGylated Liposomal Methyl Prednisolone Succinate does not Induce Infusion Reactions in Patients: A Correlation Between in Vitro Immunological and in Vivo Clinical Studies
por: Bavli, Yaelle, et al.
Publicado: (2020) -
Anticoagulants Influence the Performance of In Vitro Assays Intended for Characterization of Nanotechnology-Based Formulations
por: Cedrone, Edward, et al.
Publicado: (2017) -
Human Clinical Relevance of the Porcine Model of Pseudoallergic Infusion Reactions
por: Szebeni, János, et al.
Publicado: (2020) -
Cancer nanomedicine
por: Bhatia, Sangeeta N., et al.
Publicado: (2022)